J L Blumer
Overview
Explore the profile of J L Blumer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
1537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
James L, Capparelli E, Simpson P, Letzig L, Roberts D, Hinson J, et al.
Clin Pharmacol Ther
. 2008 Oct;
84(6):684-90.
PMID: 18923390
Acetaminophen protein adducts (APAP adducts) were quantified in 157 adolescents and children presenting at eight pediatric hospitals with the chief complaint of APAP overdose. Two of the patients required liver...
2.
Blumer J, Reed M, Steinberg F, ORiordan M, Rosen C, Springer M, et al.
Clin Pharmacol Ther
. 2007 Oct;
83(4):551-8.
PMID: 17957186
The pharmacokinetics of zolpidem was assessed in this open-label, dose-escalation study in children with insomnia. Twenty-one children, seven per age group (2-6, >6 to 12, >12 to 18 years), received...
3.
Orenstein S, Blumer J, Faessel H, McGuire J, Fung K, Li B, et al.
Aliment Pharmacol Ther
. 2002 Apr;
16(5):899-907.
PMID: 11966498
Background: The use of over-the-counter antacids has increased in children under the age of 12 years, and has been followed by an apparent increase in the use of over-the-counter histamine-2...
4.
Reed M, Rodarte A, Blumer J, Khoo K, Akbari B, Pou S, et al.
J Clin Pharmacol
. 2002 Jan;
41(12):1359-69.
PMID: 11762564
The first-dose pharmacokinetics of midazolam and its primary alpha-hydroxymetabolite were studied after single-dose administration. Eligible study patients were enrolled into one of three study arms: Arm I (midazolam/metabolite pharmacokinetic evaluation...
5.
Toltzis P, Blumer J
Pediatr Infect Dis J
. 2001 Jun;
20(6):612-8.
PMID: 11419505
No abstract available.
6.
Reed M, Stern R, ORiordan M, Blumer J
J Clin Pharmacol
. 2001 Jun;
41(6):645-54.
PMID: 11402633
The safety and pharmacokinetics of colistin were determined after first dose (n = 30) and again under steady-state conditions (n = 27) in 31 patients with cystic fibrosis receiving the...
7.
Kaplan S, Patterson L, Edwards K, Azimi P, Bradley J, Blumer J, et al.
Pediatr Infect Dis J
. 2001 May;
20(5):488-94.
PMID: 11368105
Objective: To determine the safety, tolerance, pharmacokinetics and efficacy of linezolid, a new oxazolidinone antibiotic in the treatment of community-acquired pneumonia in hospitalized children. Design: A Phase II, open label...
8.
Blumer J, Reed M, Knupp C
Pediatr Infect Dis J
. 2001 Apr;
20(3):337-42.
PMID: 11303847
Background: Because determining the pharmacokinetics of drugs used in pediatric patients allows for appropriate dosing and optimal clinical response, we have reviewed the pharmacokinetic data on the use of cefepime...
9.
Ten Eick A, Blumer J, Reed M
Drug Saf
. 2001 Mar;
24(2):119-47.
PMID: 11235817
The histamine H1 receptor antagonists (antihistamines) are an important class of medications used for the relief of common symptoms associated with hyperhistaminic conditions occurring in children and adults. This group...
10.
Winston D, Lazarus H, Beveridge R, Hathorn J, Gucalp R, Ramphal R, et al.
Clin Infect Dis
. 2001 Feb;
32(3):381-90.
PMID: 11170945
In a double-blind, multicenter trial, 541 febrile granulocytopenic patients were randomized to receive either intravenous (iv) clinafloxacin (200 mg every 12 h) or i.v. imipenem (500 mg every 6 h)...